We are live on ! Find out more
LFST icon

Lifestance Health

78 hedge funds and large institutions have $1.91B invested in Lifestance Health in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 21

17% more capital invested

Capital invested by funds: $1.64B → $1.91B (+$273M)

1.97% less ownership

Funds ownership: 78.74%76.77% (-2%)

6% less funds holding

Funds holding: 8378 (-5)

15% less call options, than puts

Call options by funds: $150K | Put options by funds: $176K

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

26% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 19

Holders
78
Holders Change
-5
Holders Change %
-6.02%
% of All Funds
1.34%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
14
Increased
28
Reduced
21
Closed
19
Calls
$150K
Puts
$176K
Net Calls
-$26K
Net Calls Change
-$32K
Name Holding Trade Value Shares
Change
Change in
Stake
TGA
1
TPG GP A
Texas
$1.16B
SP
2
Summit Partners
Massachusetts
$303M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$206M -$13.3M -1,903,376 -6%
Vanguard Group
4
Vanguard Group
Pennsylvania
$46.3M +$5.81M +832,246 +14%
SP
5
Stockbridge Partners
Massachusetts
$45.2M +$105K +15,000 +0.2%
BlackRock
6
BlackRock
New York
$34.1M +$6.39M +915,997 +22%
Principal Financial Group
7
Principal Financial Group
Iowa
$25.5M +$3.41M +488,665 +15%
RSCM
8
Rock Springs Capital Management
Maryland
$13.2M
Geode Capital Management
9
Geode Capital Management
Massachusetts
$11.6M +$3.5M +502,175 +40%
State Street
10
State Street
Massachusetts
$9.28M +$1.79M +256,009 +22%
Norges Bank
11
Norges Bank
Norway
$8M
OBWP
12
O'Brien Wealth Partners
Massachusetts
$5.76M -$2.09M -299,000 -26%
Northern Trust
13
Northern Trust
Illinois
$5.01M +$1.47M +210,187 +38%
HWM
14
Hemington Wealth Management
Virginia
$4.25M -$419K -60,000 -9%
Charles Schwab
15
Charles Schwab
California
$4.21M +$1.93M +276,764 +77%
IHAM
16
Integral Health Asset Management
New York
$3.48M +$1.04M +149,272 +40%
Morgan Stanley
17
Morgan Stanley
New York
$3.29M +$1.02M +145,990 +42%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$2.43M +$581K +83,267 +29%
SSA
19
Schonfeld Strategic Advisors
New York
$2M +$1.06M +151,575 +101%
HIP
20
HUB Investment Partners
Texas
$1.94M +$2.04M +292,389 New
Mirae Asset Global Investments
21
Mirae Asset Global Investments
South Korea
$1.76M -$23.2K -3,326 -1%
N
22
Nuveen
North Carolina
$1.58M -$49.7K -7,120 -3%
Russell Investments Group
23
Russell Investments Group
United Kingdom
$1.48M +$1.56M +224,308 New
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$1.33M +$1.23M +176,064 +729%
SAM
25
Smithbridge Asset Management
Pennsylvania
$968K +$1.02M +146,195 New

LFST Hedge Fund Activity: Q3 2022 in Review

78 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Lifestance Health (LFST) for Q3 2022, worth a combined $1.91B — up 17% from $1.64B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of LFST and 14 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 28 added.

The largest buyer was BlackRock, adding an estimated $6.39M. The largest seller was Cloverfields Capital Group, exiting entirely with an estimated $24.4M sold.

  • 78 institutional investors held Lifestance Health (LFST) as of Q3 2022, down from 83 in Q2 2022.
  • Funds reported $1.91B of Lifestance Health stock for Q3 2022, up 17% quarter-over-quarter.
  • 14 funds opened new Lifestance Health positions in Q3 2022 and 19 closed out, a net change of -5 holders.
  • The largest Lifestance Health buyer in Q3 2022 was BlackRock, an estimated $6.39M added.
  • The largest Lifestance Health seller in Q3 2022 was Cloverfields Capital Group, an estimated $24.4M sold.

Based on aggregated 13F filings for Q3 2022.